When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to help move life-changing drug candidates through preclinical development and beyond quickly and effectively.
Our preclinical oncology solutions consist of in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies, ex vivo assessments and focal radiation capabilities to support your oncology research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models providing you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough.
Explore our comprehensive list of oncological cell lines.
Take advantage of the widest breadth of analysis tools and models in the industry.
Advance personalized medicine approaches with our patient-derived xenografts models
Access a full suite of molecular and cellular biology assays as well as advanced tissue analytics.
For over a decade, we have offered an industry-leading array of technology platforms to deliver efficient quality results:
View in-depth analysis, including growth curves and treatment response, for preclinical tumor models and technology in our model and tech spotlights.
Improve your therapeutic efficacy predictions with our fully characterized patient-derived xenografts (PDX) representing multiple histotypes.
With a broad range of disseminated and subcutaneous tumor models characterized in NSG mice, and a scientific team that knows how to apply them, we can guide selection of the right tumor model for your Chimeric Antigen Receptor (CAR) T-cell study or other ACT study.
Expedite your candidate selection with quick start times, expert scientific collaboration and innovative science.
To understand how anticancer therapeutics behave in patients, we need preclinical oncology models that mimic actual human tissue. Reduce the failure rate of your candidate anticancer trials with our advances in tumor-specific 3D
The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.
